Danon disease: clinical features, evaluation, and management

Ryan S D'souza; Cecilia Levandowski; Dobromir Slavov; Sharon L Graw; Larry A Allen; Eric Adler; Luisa Mestroni; Matthew R G Taylor

doi:10.1161/CIRCHEARTFAILURE.114.001105

Danon disease: clinical features, evaluation, and management

Circ Heart Fail. 2014 Sep;7(5):843-9. doi: 10.1161/CIRCHEARTFAILURE.114.001105.

Authors

Ryan S D'souza¹, Cecilia Levandowski¹, Dobromir Slavov¹, Sharon L Graw¹, Larry A Allen¹, Eric Adler¹, Luisa Mestroni¹, Matthew R G Taylor²

Affiliations

¹ From the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.).
² From the Adult Medical Genetics Program and Division of Cardiology, University of Colorado, Denver (R.S.D., C.L., D.S., S.L.G., L.A.A., L.M., M.R.G.T.); and Division of Cardiology, University of California, San Diego (E.A.). matthew.taylor@ucdenver.edu.

PMID: 25228319
PMCID: PMC4169002
DOI: 10.1161/CIRCHEARTFAILURE.114.001105

No abstract available

Keywords: cardiomyopathy, dilated; cardiomyopathy, hypertrophic; genetics; glycogen storage disease type IIb; lysosomal-associated membrane protein 2; molecular biology; mutation.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

MeSH terms

DNA / genetics*
DNA Mutational Analysis
Disease Management*
Genetic Predisposition to Disease
Global Health
Glycogen Storage Disease Type IIb* / diagnosis
Glycogen Storage Disease Type IIb* / epidemiology
Glycogen Storage Disease Type IIb* / genetics
Humans
Lysosomal-Associated Membrane Protein 2 / biosynthesis
Lysosomal-Associated Membrane Protein 2 / genetics
Morbidity / trends
Mutation

Substances

LAMP2 protein, human
Lysosomal-Associated Membrane Protein 2
DNA

Publication types

MeSH terms

Substances

Grants and funding